ClinicalTrials.Veeva

Menu

The Role of Skin Microbiota in Hepatic or Renal Pruritus

Z

Zagazig University

Status

Enrolling

Conditions

Renal Failure
Hepatic Failure
Pruritus

Treatments

Diagnostic Test: Isolation of skin microbiota

Study type

Observational

Funder types

Other

Identifiers

NCT05604469
9802-11-10-2022

Details and patient eligibility

About

  • Various neurotransmitters may share in the pathogenesis of hepatic and renal itching.
  • Skin microbiota may share in the pathogenesis of pruritus.

Full description

Uremic pruritus (UP) is a frequent phenomenon and it is regarded as one of the most bothersome symptoms in patients with chronic renal disease. The prevalence of UP is still high and reported in around 40% to 50%. UP has an important impact on patients' quality of life and sleep, depression, and increased mortality. The pathogenesis of UP remains blurry, although many different factors have been indicated in the etiology of this symptom, including increased systemic inflammation, abnormal serum parathyroid hormone, calcium, and phosphorus levels, an imbalance in opiate receptors, a neuropathic process, or even skin dryness. This is why until now there is no specific treatment for patients with UP and many of the available therapeutic modalities are not satisfactory Pruritus in liver diseases can often be a debilitating symptom causing significant impairment in quality of life. Not all patients with liver disease develop pruritus and its prevalence varies depending on the underlying cause of liver disease. It is more common in conditions characterized by bile duct inflammatory destruction than in those characterized by hepatocellular injury.

Cutaneous microbiota delivers a diverse and far-reaching influence on our physiology by calling upon the host nervous system. Bacteria make metabolites, toxins, and structural components that are recognized by peripheral and central neurons via matching receptors. Microbiota also indirectly affects neural function by causing endocrine (i.e., keratinocytes) and immune cells to transmit signals (i.e., cytokines, proteases). Itch is a prototypic sensory neural function, and the microbiota propels the itch-scratch cycle.

Enrollment

60 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients of both sexes. Patients with hepatic illness (autoimmune liver diseases, chronic viral hepatitis, and drug-induced liver injury) or Patients with renal failure Willing to sign an informed consent.

Trial design

60 participants in 4 patient groups

Group A (liver faluire patients with pruritus)
Description:
Patients with hepatic illness (autoimmune liver diseases, chronic viral hepatitis, and drug-induced liver injury)
Treatment:
Diagnostic Test: Isolation of skin microbiota
Group B (liver faluire patients without pruritus)
Description:
Patients with hepatic illness (autoimmune liver diseases, chronic viral hepatitis, and drug-induced liver injury)
Treatment:
Diagnostic Test: Isolation of skin microbiota
Group C (renal faluire patients with pruritus)
Treatment:
Diagnostic Test: Isolation of skin microbiota
Group D (renal faluire patients without pruritus)
Treatment:
Diagnostic Test: Isolation of skin microbiota

Trial contacts and locations

1

Loading...

Central trial contact

Reham Essam, MD; Reham Essam

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems